- Home
- LYRA vs GTIM Comparison
LYRA vs GTIM Comparison
Compare LYRA & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- GTIM
- Stock Information
- Founded
- LYRA 2005
- GTIM 1987
- Country
- LYRA United States
- GTIM United States
- Employees
- LYRA N/A
- GTIM N/A
- Industry
- LYRA Medical/Dental Instruments
- GTIM Restaurants
- Sector
- LYRA Health Care
- GTIM Consumer Discretionary
- Exchange
- LYRA Nasdaq
- GTIM Nasdaq
- Market Cap
- LYRA 15.0M
- GTIM 17.1M
- IPO Year
- LYRA 2020
- GTIM 1990
- Fundamental
- Price
- LYRA $7.05
- GTIM $1.64
- Analyst Decision
- LYRA Buy
- GTIM
- Analyst Count
- LYRA 2
- GTIM 0
- Target Price
- LYRA $16.00
- GTIM N/A
- AVG Volume (30 Days)
- LYRA 28.3K
- GTIM 36.1K
- Earning Date
- LYRA 08-12-2025
- GTIM 08-07-2025
- Dividend Yield
- LYRA N/A
- GTIM N/A
- EPS Growth
- LYRA N/A
- GTIM 17.03
- EPS
- LYRA N/A
- GTIM 0.12
- Revenue
- LYRA $770,000.00
- GTIM $143,398,000.00
- Revenue This Year
- LYRA N/A
- GTIM N/A
- Revenue Next Year
- LYRA $139.18
- GTIM N/A
- P/E Ratio
- LYRA N/A
- GTIM $13.91
- Revenue Growth
- LYRA N/A
- GTIM 1.78
- 52 Week Low
- LYRA $3.81
- GTIM $1.34
- 52 Week High
- LYRA $37.50
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- LYRA 41.94
- GTIM 56.95
- Support Level
- LYRA $6.51
- GTIM $1.34
- Resistance Level
- LYRA $7.57
- GTIM $1.43
- Average True Range (ATR)
- LYRA 0.55
- GTIM 0.08
- MACD
- LYRA 0.14
- GTIM 0.03
- Stochastic Oscillator
- LYRA 47.71
- GTIM 71.43
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.